1-3 of 3
Meenakshi Anurag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

Vera J. Suman, Lili Du, Tanya Hoskin, Meenakshi Anurag, Cynthia Ma, Isabelle Bedrosian, Kelly K. Hunt, Matthew J. Ellis, W. Fraser Symmans
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3287–3295.
https://doi.org/10.1158/1078-0432.CCR-22-0068
Published: 02 August 2022
View article titled, Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)
Open the PDF for Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031) in another window
Includes: Supplementary data
Journal Articles

CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?

Meenakshi Anurag, Svasti Haricharan, Matthew J. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (1): 3–5.
https://doi.org/10.1158/1078-0432.CCR-19-3119
Published: 03 January 2020
View article titled, CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?
Open the PDF for CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree? in another window
Journal Articles

Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers

Meenakshi Anurag, Nindo Punturi, Jeremy Hoog, Matthew N. Bainbridge, Matthew J. Ellis, Svasti Haricharan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (19): 4887–4899.
https://doi.org/10.1158/1078-0432.CCR-17-3702
Published: 01 October 2018
View article titled, Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
Open the PDF for Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers in another window
Includes: Supplementary data